» Articles » PMID: 39001453

The Paradox of Ribosomal Insufficiency Coupled with Increased Cancer: Shifting the Perspective from the Cancer Cell to the Microenvironment

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Jul 13
PMID 39001453
Authors
Affiliations
Soon will be listed here.
Abstract

Ribosomopathies are defined as inherited diseases in which ribosomal factors are mutated. In general, they present multiorgan symptoms. In spite of the fact that in cellular models, ribosomal insufficiency leads to a reduced rate of oncogenic transformation, patients affected by ribosomopathies present a paradoxical increase in cancer incidence. Several hypotheses that explain this paradox have been formulated, mostly on the assumption that altered ribosomes in a stem cell induce compensatory changes that lead to a cancer cell. For instance, the lack of a specific ribosomal protein can lead to the generation of an abnormal ribosome, an oncoribosome, that itself leads to altered translation and increased tumorigenesis. Alternatively, the presence of ribosomal stress may induce compensatory proliferation that in turns selects the loss of tumor suppressors such as p53. However, modern views on cancer have shifted the focus from the cancer cell to the tumor microenvironment. In particular, it is evident that human lymphocytes are able to eliminate mutant cells and contribute to the maintenance of cancer-free tissues. Indeed, many tumors develop in conditions of reduced immune surveillance. In this review, we summarize the current evidence and attempt to explain cancer and ribosomopathies from the perspective of the microenvironment.

References
1.
Nicolas E, Parisot P, Pinto-Monteiro C, de Walque R, De Vleeschouwer C, Lafontaine D . Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress. Nat Commun. 2016; 7:11390. PMC: 4897761. DOI: 10.1038/ncomms11390. View

2.
Kim J, You K, Kim I, Cho B, Kim C, Kim D . Over-expression of the ribosomal protein L36a gene is associated with cellular proliferation in hepatocellular carcinoma. Hepatology. 2004; 39(1):129-38. DOI: 10.1002/hep.20017. View

3.
Brown I, Lafita-Navarro M, Conacci-Sorrell M . Regulation of Nucleolar Activity by MYC. Cells. 2022; 11(3). PMC: 8834138. DOI: 10.3390/cells11030574. View

4.
Valli R, Penzo M . Editorial: Inherited and acquired ribosomopathies: missing puzzle pieces. Front Genet. 2023; 14:1194788. PMC: 10131078. DOI: 10.3389/fgene.2023.1194788. View

5.
Ceci M, Gaviraghi C, Gorrini C, Sala L, Offenhauser N, Marchisio P . Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature. 2003; 426(6966):579-84. DOI: 10.1038/nature02160. View